Triglyceride-Rich Lipoproteins and Coronary Artery Disease Risk
Author:
Affiliation:
1. From the Departments of Genetics and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Link
https://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.114.305172
Reference74 articles.
1. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2. Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
3. High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial InfarctionThe IDEAL Study: A Randomized Controlled Trial
4. Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges
5. Association between postprandial triglycerides and coronary artery disease detected by coronary computed tomography angiography
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk;New England Journal of Medicine;2024-09-02
2. Omega-3 fatty acids in the treatment of heart failure;Current Problems in Cardiology;2024-09
3. Local and systemic factors associated with quantitative stiffness of carotid plaque;Acta Neurochirurgica;2024-01-30
4. Pemafibrate;Clinical Lipidology;2024
5. High-Density Lipoprotein and Heart Failure;Reviews in Cardiovascular Medicine;2023-11-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3